Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / CSPHF - CStone's Commercialization Capacity Put To Test With Latest Drug Approval


CSPHF - CStone's Commercialization Capacity Put To Test With Latest Drug Approval

  • Company’s four drug approvals in a year will contribute major revenue, but will also challenge CStone’s ability to commercialize its products.
  • Its rollout of four new drugs will be a major test of CStone’s commercialization ability, prompting it to set up an in-house commercialization team and enlist outside help.
  • The company needed just six months to finish the application process and get the regulatory nod for Ivosidenib, its latest approved drug.

For further details see:

CStone's Commercialization Capacity Put To Test With Latest Drug Approval
Stock Information

Company Name: CStone Pharmaceuticals - Ordinary Shares
Stock Symbol: CSPHF
Market: OTC

Menu

CSPHF CSPHF Quote CSPHF Short CSPHF News CSPHF Articles CSPHF Message Board
Get CSPHF Alerts

News, Short Squeeze, Breakout and More Instantly...